J Mendelsohn1, C P Dinney. Show Affiliations » 1. University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA.
Abstract
Entities: Species
Mesh: See more » AnimalsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useApoptosisCarcinoma, Transitional Cell/metabolismCarcinoma, Transitional Cell/pathologyCarcinoma, Transitional Cell/physiopathologyCarcinoma, Transitional Cell/therapyCetuximabErbB Receptors/antagonists & inhibitorsErbB Receptors/metabolismNeoplasm InvasivenessNeovascularization, Physiologic/physiologyReceptor Protein-Tyrosine Kinases/antagonists & inhibitorsSignal TransductionUrinary Bladder Neoplasms/metabolismUrinary Bladder Neoplasms/pathologyUrinary Bladder Neoplasms/physiopathologyUrinary Bladder Neoplasms/therapy
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsErbB ReceptorsReceptor Protein-Tyrosine KinasesCetuximab
Year: 2001 PMID: 11257658
Source DB: PubMed Journal: J Urol ISSN: 0022-5347 Impact factor: 7.450